<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Brief Funct Genomics</journal-id><journal-id journal-id-type="iso-abbrev">Brief Funct Genomics</journal-id><journal-id journal-id-type="publisher-id">bfgp</journal-id><journal-id journal-id-type="hwp">bfgp</journal-id><journal-title-group><journal-title>Briefings in Functional Genomics</journal-title></journal-title-group><issn pub-type="ppub">2041-2649</issn><issn pub-type="epub">2041-2657</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24907364</article-id><article-id pub-id-type="pmc">4168661</article-id><article-id pub-id-type="doi">10.1093/bfgp/elu013</article-id><article-id pub-id-type="publisher-id">elu013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Papers</subject></subj-group></article-categories><title-group><article-title>TAL effectors: tools for DNA Targeting</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jankele</surname><given-names>Radek</given-names></name><xref ref-type="bio" rid="d35e36">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Svoboda</surname><given-names>Petr</given-names></name><xref ref-type="bio" rid="d35e47">*</xref></contrib></contrib-group><author-notes><corresp>Corresponding author. P. Svoboda, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic. Tel: <phone>+420 241063147</phone>; Fax: <fax>+420 224310955</fax>; E-mail: <email>svobodap@img.cas.cz</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>06</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>06</day><month>6</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>13</volume><issue>5</issue><issue-title>Special Issue: Rare variants and disease</issue-title><fpage>409</fpage><lpage>419</lpage><permissions><copyright-statement>&#x000a9; The Author 2014. Published by Oxford University Press.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/3.0/" license-type="creative-commons"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><italic>Xanthomonas</italic> phytopathogenic bacteria produce unique transcription activator-like effector (TALE) proteins that recognize and activate specific plant promoters through a set of tandem repeats. A unique TALE-DNA-binding code uses two polymorphic amino acids in each repeat to mediate recognition of specific nucleotides. The order of repeats determines effector&#x02019;s specificity toward the cognate nucleotide sequence of the sense DNA strand. Artificially designed TALE-DNA-binding domains fused to nuclease or activation and repressor domains provide an outstanding toolbox for targeted gene editing and gene regulation in research, biotechnology and gene therapy. Gene editing with custom-designed TALE nucleases (TALENs) extends the repertoire of targeted genome modifications across a broad spectrum of organisms ranging from plants and insect to mammals.</p></abstract><kwd-group><kwd>TALE</kwd><kwd>TALEN</kwd><kwd>ZFN</kwd><kwd>FokI</kwd><kwd>DNA editing</kwd></kwd-group><counts><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Engineered DNA-binding domains (DBDs) fused with different catalytic or effector domains allow researchers to edit DNA sequences or regulate gene expression at specific DNA loci within complex eukaryotic genomes. There are two main classes of engineered site-specific DBDs: zinc finger-based DBDs and transcription activator-like effector (TALE)-based DBDs. Site-specific zinc finger nucleases (ZFN) for genome editing (reviewed in [<xref rid="elu013-B1" ref-type="bibr">1</xref>]) pawed the road for the TALE Nuclease (TALEN) technology, which is based on a unique modular DBD of TALEs from plant-pathogenic bacterial genus <italic>Xanthomonas.</italic> A commonly used nuclease domain in ZNFs and TALENs is the dimerizing FokI endonuclease cleavage domain, which introduces a double-strand break (DSB) [<xref rid="elu013-B2" ref-type="bibr">2</xref>, <xref rid="elu013-B3" ref-type="bibr">3</xref>]. DSBs at targeted loci rapidly increase local frequencies of homologous recombination. This enables the extension of genetic manipulations to virtually any model organisms and cell line.</p><p>In this review, we first recapitulate discovery of TALEs and deciphering of their binding code. Next, we describe the structure of TALE DBD and its implications for biotechnology. Finally, we discuss TALE-based nucleases and genome regulators as distinct categories of engineered site-specific proteins that share a common DBD but differ in their effector domains, hence in their mode of action.</p></sec><sec><title>TALEs&#x02014;VIRULENCE FACTORS OF <italic>XANTHOMONAS</italic></title><p>Gram-negative &#x003b3;-proteobacteria of the genus <italic>Xanthomonas</italic> are important plant pathogens affecting worldwide yields of crop plants such as wheat, rice, cassava or cotton. <italic>Xanthomonas</italic> enter host plants through surface wounds or natural openings and multiply inside plant tissues (reviewed in detail in [<xref rid="elu013-B4" ref-type="bibr">4</xref>]). To facilitate a productive bacterial infection in plants, <italic>Xanthomonas</italic> secrete a cocktail of effector proteins into host cells, including the TALE family proteins (originally denoted <italic>AvrBs3</italic>-family effectors) that function as eukaryotic-like transcription factors. TALEs are secreted directly into the plant cell cytoplasm [<xref rid="elu013-B5" ref-type="bibr">5</xref>] and transported into the nucleus via importin-&#x003b1; [<xref rid="elu013-B6" ref-type="bibr">6</xref>]. Recognition of specific promoters and subsequent interaction with the basal transcriptional machinery induce transcription of specific host plant genes.</p><p>TALEs exhibit exceptional DNA-binding specificity stemming from a unique domain organization [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B8" ref-type="bibr">8</xref>] (<xref ref-type="fig" rid="elu013-F1">Figure 1</xref>A). The common feature of natural TALEs is their DBD composed of 7&#x02013;34 highly homologous direct repeats in the central part of the protein [<xref rid="elu013-B9" ref-type="bibr">9</xref>]. Typically, each repeat module (<xref ref-type="fig" rid="elu013-F1">Figure 1</xref>B) has 34 amino acids (aa) in length; the last C-terminal truncated repeat, so-called half-repeat, consists of 20 aa. Two polymorphic aa residues at positions 12 and 13 form the repeat-variable diresidue (RVD), where the residue 13 is responsible for preferential binding of the repeat module to a single specific nucleotide in the major groove of target DNA sequence (summarized in [<xref rid="elu013-B10" ref-type="bibr">10</xref>]). The binding code was deciphered independently in 2009 by two groups who found a simple cipher, where common RVDs HD, NG/HG and NI recognize almost exclusively cytosine, thymine and adenine, respectively; whereas NN or NS has more degenerated specificity [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B8" ref-type="bibr">8</xref>] (<xref ref-type="fig" rid="elu013-F1">Figure 1</xref>C). The order of repeat modules from N to C-terminus within TALE DBD then corresponds to the recognized DNA sequence in 5&#x02032; to 3&#x02032; direction such that each repeat contacts one specific DNA base pair via the RVD.
<fig id="elu013-F1" position="float"><label>Figure 1:</label><caption><p>TALE domain composition and DNA-binding code. (<bold>A</bold>) TALEs contain nuclear localization signals (NLS) and an activation domain (AD) to function as transcriptional activators. A central tandem repeat domain confers specific DNA-binding and host specificity. Translocation signal (TD) and four cryptic repeats required for initiation of DNA binding and for the recognition of 5&#x02032;-T<sup>0</sup> are located at the N-terminus (chequered rectangles). Each 34 amino acid (aa) long repeat in the CRD binds to one nucleotide with specificity determined mainly by aa at position 13. One sample repeat is shown below the protein scheme. Numbers 12/13 refer to aa positions within the repeat. (<bold>B</bold>) Structure of an individual TALE repeat module. The repeat has 34 amino acids in length and takes a loop&#x02013;helix secondary structure where two &#x003b1;-helices are linked by short &#x02018;RVD loop&#x02019;. The residue 13 is responsible for preferential binding of the repeat module to a single specific nucleotide in the major groove of target DNA sequence (C, in this case). (<bold>C</bold>) Repeat types have specificity for one or several nucleotides. Only bases of the DNA leading strand are shown. Adapted from [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B9" ref-type="bibr">9</xref>, <xref rid="elu013-B10" ref-type="bibr">10</xref>, <xref rid="elu013-B11" ref-type="bibr">11</xref>].</p></caption><graphic xlink:href="elu013f1p"/></fig></p><p>While the TALE central repeat domain (CRD) determines the specificity, the DBD is further extended &#x0223c;150 aa into the N-terminal region (NTR), immediately preceding the first canonical repeat [<xref rid="elu013-B12" ref-type="bibr">12&#x02013;14</xref>]. This region is composed of four cryptic repeats and substantially contributes to the overall basic charge of TALE proteins [<xref rid="elu013-B12" ref-type="bibr">12</xref>, <xref rid="elu013-B15" ref-type="bibr">15</xref>]. The NTR is necessary for binding of TALEs to DNA and mediates interaction with a conserved thymine at position 0 (discussed in more detail later). The N-terminus of natural TALE proteins also contains secretion and translocation signals required for delivery into host cells [<xref rid="elu013-B16" ref-type="bibr">16</xref>]. The C-terminal region carries conserved three monopartite nuclear localization signals and a conserved eukaryotic-like acidic transcriptional activation domain [<xref rid="elu013-B6" ref-type="bibr">6</xref>, <xref rid="elu013-B17" ref-type="bibr">17&#x02013;19</xref>]. Notably, TALE-like proteins were also identified in the plant pathogenic bacterium <italic>Ralstonia solanacearum</italic> [<xref rid="elu013-B20" ref-type="bibr">20</xref>, <xref rid="elu013-B21" ref-type="bibr">21</xref>] offering additional options for engineering DBDs.</p></sec><sec><title>SPECIFICITY OF DNA BINDING BY TALEs</title><p>Crystallographic studies of TALEs bound to their target sequences unraveled that TALE DBD forms a right-handed superhelical assembly wrapped around B-form DNA duplex (<xref ref-type="fig" rid="elu013-F2">Figure 2</xref>) and explained specific repeat-nucleotide interactions [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B23" ref-type="bibr">23</xref>, <xref rid="elu013-B24" ref-type="bibr">24</xref>]. Individual TALE repeats have helix&#x02013;loop&#x02013;helix secondary structure where two &#x003b1;-helices are linked by short &#x02018;RVD loop&#x02019; (<xref ref-type="fig" rid="elu013-F1">Figure 1</xref>B). The first short &#x003b1;-helix spans residues 3&#x02013;11 and the longer bended second &#x003b1;-helix spans residues 15&#x02013;33. The RVD loop of each TALE repeat reaches into the major groove of the DNA duplex and contacts a single nucleotide in the sense strand with the residue at position 13 [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B23" ref-type="bibr">23</xref>]. Interestingly, the residue at position 12 (mainly histidine or asparagine) points away from the major groove and does not contribute to the specific base recognition but, rather stabilizes the position of the RVD loop [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B23" ref-type="bibr">23</xref>]. Within each repeat, lysine and glutamine residues at positions 16 and 17, respectively, contribute to non-specific interactions with negatively charged DNA backbone [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B23" ref-type="bibr">23</xref>]. The characteristic angle between inter-repeat helices distinguishes the TALE repeat domain from other known &#x003b1;-helical repeat domains [<xref rid="elu013-B23" ref-type="bibr">23</xref>].
<fig id="elu013-F2" position="float"><label>Figure 2:</label><caption><p>Comparison of zinc finger and TALE DNA-binding domains. A single zinc finger module recognizes three nucleotides of DNA while a TALE repeat module recognizes a single nucleotide of DNA. Next are shown front and lateral views of zinc finger and TALE DBDs. Shown is a six-finger zinc finger protein that consists of six tandem repeats of C2H2 zinc finger motifs, each consisting of approximately 30 amino acids and a TALE DBD consisting of 2 cryptic repeats and 22 canonical repeat modules. Structures were rendered using available structural information deposited in the Protein Data Bank [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B22" ref-type="bibr">22</xref>].</p></caption><graphic xlink:href="elu013f2p"/></fig></p><sec><title>Recognition of nucleotides in the cognate sequence</title><p>Different types of interactions are responsible for recognition of different nucleotides. This is important for designing custom TALE domains. Direct H- bonds are involved in base selectivity for C, G, G/A and A/G/C mediated by RVDs HD, NH, NN and NS, respectively. Weaker van der Waals contacts are responsible for base selectivity of NI and NG for A and T, respectively [<xref rid="elu013-B15" ref-type="bibr">15</xref>,, <xref rid="elu013-B23" ref-type="bibr">23</xref>
<xref rid="elu013-B24" ref-type="bibr">24</xref>]. Nucleotide-binding specificity is determined not only by possible contacts with nucleotides but also by steric exclusion of interactions with alternative nucleotides (reviewed in [<xref rid="elu013-B25" ref-type="bibr">25</xref>]). Notably, the use of HD and NG enables partial discrimination of targets with unmethylated or methylated cytosines with custom TALEs because NG can accommodate a methylated cytosine, whereas HD does not [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B23" ref-type="bibr">23</xref>]. In addition, a 33 aa long N* repeat (missing the residue at position 13) exhibits complete recognition promiscuity explained by absenting physical contact with nucleotides [<xref rid="elu013-B15" ref-type="bibr">15</xref>]. Therefore, N* also allows for accommodating methylated cytosines and for designing TALE domains with highly degenerated target specificity [<xref rid="elu013-B26" ref-type="bibr">26</xref>].</p><p>RVDs NI, HD, NH/NK and NG are highly specific, recognizing A, C, G and T nucleotides, respectively [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B8" ref-type="bibr">8</xref>]. NG and HD bind cognate bases with high, NH with &#x02018;intermediate&#x02019; and NI and NK with weaker affinity [<xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B27" ref-type="bibr">27&#x02013;29</xref>]. NN and NS have degenerated specificity; NN repeat selects both for G and A (with a preference for G) and binds them with high affinity [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B29" ref-type="bibr">29&#x02013;32</xref>]. NS can bind A, C and G; interaction with T is probably sterically excluded [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B8" ref-type="bibr">8</xref>, <xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B25" ref-type="bibr">25</xref>]. Guanine is exclusively recognized by NK and NH [<xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B29" ref-type="bibr">29</xref>, <xref rid="elu013-B32" ref-type="bibr">32</xref>, <xref rid="elu013-B33" ref-type="bibr">33</xref>]. NH recognizes guanine with &#x02018;intermediate&#x02019; affinity, whereas NK was classified as &#x02018;weak&#x02019; and also performed poorly in reporter assays compared with both NN and NH [<xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B29" ref-type="bibr">29</xref>, <xref rid="elu013-B30" ref-type="bibr">30</xref>, <xref rid="elu013-B32" ref-type="bibr">32</xref>, <xref rid="elu013-B34" ref-type="bibr">34</xref>, <xref rid="elu013-B35" ref-type="bibr">35</xref>]. Thus, NH seems to be a good choice for G targeting, especially if flanked by a few strong RVDs (NG, NN and HD) [<xref rid="elu013-B29" ref-type="bibr">29</xref>, <xref rid="elu013-B32" ref-type="bibr">32</xref>]. Repeats included in available TALE assembly kits (HD, NG, NI, NN, NH and NK) are further referred as standard RVDs, all other RVDs are referred as &#x02018;non-standard&#x02019; (<xref ref-type="fig" rid="elu013-F1">Figure 1</xref>C).</p><p>TALE-DNA-binding mechanism is apparently asymmetric across the protein&#x02013;DNA interface [<xref rid="elu013-B27" ref-type="bibr">27</xref>]. NTR ensures 5&#x02032;-T<sup>0</sup> recognition and probably serves as a binding-anchor from which the protein wraps around a DNA helix and probes a nucleotides sequence [<xref rid="elu013-B12" ref-type="bibr">12</xref>]. Therefore, mutations at the 5&#x02032; end of a corresponding TALE target site impair activity more than mutations at the 3&#x02032; end [<xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B31" ref-type="bibr">31</xref>]. Furthermore, too many strong RVDs at the N-terminal part of CRD may pose a risk of multiple off-target effects. At the same time, weak RVDs at the C-terminal part of CRD may also impair TALE activity [<xref rid="elu013-B27" ref-type="bibr">27</xref>].</p><p>It seems that evolutionary optimal length of TALE arrays is between 17 and 20 RVDs, as most of natural TALEs fall within this range [<xref rid="elu013-B9" ref-type="bibr">9</xref>]. This possibly reflects a critical TALE size above which deformations in superhelical assembly could lead to registration errors. Thus, adding more repeats to an array may have no positive effect to overall binding affinity [<xref rid="elu013-B9" ref-type="bibr">9</xref>, <xref rid="elu013-B15" ref-type="bibr">15</xref>, <xref rid="elu013-B27" ref-type="bibr">27</xref>]. Moreover, a systematic study of TALEN specificity revealed that excess non-specific DNA-binding energy (which is increasing with an array length) results in tolerating more mismatches and, therefore, in greater off-target cleavage [<xref rid="elu013-B31" ref-type="bibr">31</xref>]. Accordingly, TALENs mutated at the C-terminal domain to reduce non-specific DNA-binding energy still retain high activity and exhibit improved specificity [<xref rid="elu013-B31" ref-type="bibr">31</xref>].</p></sec><sec><title>The invariant 5&#x02032;-thymine base</title><p>Interestingly, well-conserved thymine is present at the position 0 (T<sup>0</sup>) of most of natural TALE target sites [<xref rid="elu013-B8" ref-type="bibr">8</xref>] and is necessary for full target gene activation [<xref rid="elu013-B7" ref-type="bibr">7</xref>, <xref rid="elu013-B36" ref-type="bibr">36</xref>] and activity of TALE fusion proteins [<xref rid="elu013-B12" ref-type="bibr">12</xref>, <xref rid="elu013-B37" ref-type="bibr">37</xref>, <xref rid="elu013-B38" ref-type="bibr">38</xref>]. Although structural data can explain the 5&#x02032;-T<sup>0</sup> preference [<xref rid="elu013-B15" ref-type="bibr">15</xref>], TALE fusion proteins functioning on 5&#x02032;-T<sup>0</sup>-deficient target sites were also reported [<xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B28" ref-type="bibr">28</xref>, <xref rid="elu013-B39" ref-type="bibr">39</xref>]. The significance of 5&#x02032;-T<sup>0</sup> differs for wild-type TALEs and artificial TALEs created with standard RVDs suggesting that the latter bind DNA with higher affinity and may not require the invariant 5&#x02019;-T<sup>0</sup> [<xref rid="elu013-B27" ref-type="bibr">27</xref>]. Recently, redesigned scaffolds allowing non-constrained target site selection were reported [<xref rid="elu013-B38" ref-type="bibr">38</xref>]. However, it is advisable to design artificial TALEs with 5&#x02019;-T<sup>0</sup>, as this natural TALE&#x02019;s feature does not seriously constrain target site selection in eukaryotic genomes.</p></sec></sec><sec><title>USE OF TALE DBD FOR GENE EDITING AND REGULATION</title><p>In their pioneering work, Boch <italic>et al.</italic> [<xref rid="elu013-B7" ref-type="bibr">7</xref>] demonstrated that artificial TALEs could be synthesized, hence allowing for exploitation of the TALE-binding code for targeting almost any DNA sequence with artificial TALE DBDs. Properties of the TALE DBD offer a great potential for research, biotechnology and gene therapy. Repeat modules can be arranged in a desired order to produce a DBD with high sequence specificity. Such a DBD can be combined with a catalytic or effector domain, e.g. a nuclease to obtain an exceptional tool for DNA editing [<xref rid="elu013-B40" ref-type="bibr">40</xref>]. High specificity, reliable activity and low cytotoxicity are desired features of an ideal customized nuclease.</p><p>TALE fusion proteins use the C-terminal region downstream of CRD as a linker between TALE DBD and the effector domain. The optimal length of the linker may vary for different effector domains, e.g. a short 17&#x02013;65 aa linker is used for the dimerizing FokI nuclease domain [<xref rid="elu013-B13" ref-type="bibr">13</xref>, <xref rid="elu013-B28" ref-type="bibr">28</xref>], whereas a longer linker (&#x0223c;65 aa) was used for activation domains [<xref rid="elu013-B14" ref-type="bibr">14</xref>, <xref rid="elu013-B28" ref-type="bibr">28</xref>]. This difference likely reflects different steric requirements of particular effector domains.</p><sec><title>Gene editing with TALE nucleases</title><p>Organisms repair DSBs through two major pathways: non-homologous end joining (NHEJ) and homologous recombination (HR). NHEJ is an error-prone process, which often leads to small insertions or deletions (indels) at the break site, and thus can cause a frameshift mutation in the coding sequence of targeted gene. HR is generally an error-free process, which can use a sister chromatid or exogenous homologous template to repair the damage. Traditional gene targeting relies on DSB-independent HR to replace (knock-in) or disrupt (knock-out) gene sequences in a pre-determined locus (reviewed in [<xref rid="elu013-B41" ref-type="bibr">41</xref>]). Low frequency of DSB-independent HR limits this approach to just a few model organisms (e.g. <italic>Mus musculus,</italic> or <italic>Saccharomyces cerevisiae</italic>) and cell types (e.g. embryonic stem cells). Even in suitable cells, the frequency of HR with the donor sequence is low (1/10<sup>4</sup><sup>&#x02013;</sup><sup>7</sup>), requiring some selection system to identify cells where HR occurred. A remedy for this problem represents nuclease-induced DSBs, which stimulate HR [<xref rid="elu013-B42" ref-type="bibr">42</xref>, <xref rid="elu013-B43" ref-type="bibr">43</xref>]. This nuclease-mediated approach is referred to as gene editing.</p><p>One of the first tools for gene editing was synthetic ZFN (<xref ref-type="fig" rid="elu013-F2">Figure 2</xref>). A ZFN is created by linking the FokI nuclease domain [<xref rid="elu013-B44" ref-type="bibr">44</xref>] to a Cis<sub>2</sub>His<sub>2</sub> zinc-finger array, which provides the sequence specificity [<xref rid="elu013-B3" ref-type="bibr">3</xref>]. The FokI nuclease domain functions as a dimer [<xref rid="elu013-B2" ref-type="bibr">2</xref>]; therefore, two zinc-finger arrays, each carrying a FokI monomer, are targeted to neighboring sites between which FokI dimerization occurs [<xref rid="elu013-B1" ref-type="bibr">1</xref>]. ZFN technology yielded substantial achievements in a variety of model organisms and cell types, which were previously inaccessible by the classical gene targeting methods. In contrast to traditional gene targeting, gene editing with custom nucleases yields high mutation frequencies; therefore, selectable markers are not necessary. Principles established during more than a decade of ZFNs research were subsequently adapted to TALENs once the TALE-DNA-binding code was deciphered. In TALENs, the FokI nuclease (or its heterodimeric variants [<xref rid="elu013-B45" ref-type="bibr">45</xref>, <xref rid="elu013-B46" ref-type="bibr">46</xref>], <xref ref-type="fig" rid="elu013-F3">Figure 3</xref>A) is recruited to two adjacent target sites separated with a short spacer (12&#x02013;20 nt) (reviewed in [<xref rid="elu013-B48" ref-type="bibr">48</xref>]). In contrast to a zinc-finger DBD, where one finger predominantly recognizes a nucleotide triplet [<xref rid="elu013-B49" ref-type="bibr">49</xref>], each module of TALE DBD recognizes a single nucleotide within the target sequence (<xref ref-type="fig" rid="elu013-F2">Figure 2</xref>). The initial TALEN fusions with the homodimeric FokI demonstrated successful TALEN-mediated alterations [<xref rid="elu013-B28" ref-type="bibr">28</xref>, <xref rid="elu013-B37" ref-type="bibr">37</xref>, <xref rid="elu013-B40" ref-type="bibr">40</xref>, <xref rid="elu013-B50" ref-type="bibr">50</xref>].
<fig id="elu013-F3" position="float"><label>Figure 3:</label><caption><p>TALE-based gene editors and regulators. (<bold>A</bold>) A pair of TALENs with a heterodimerizing FokI domain [<xref rid="elu013-B47" ref-type="bibr">47</xref>]. (<bold>B</bold>) A TALE-based transcriptional activator [<xref rid="elu013-B14" ref-type="bibr">14</xref>]. (<bold>C</bold>) A TALE-based transcriptional repressor [<xref rid="elu013-B32" ref-type="bibr">32</xref>].</p></caption><graphic xlink:href="elu013f3p"/></fig></p><p>TALEN technology was successfully used for targeted genome editing in yeasts [<xref rid="elu013-B50" ref-type="bibr">50</xref>], <italic>Drosophila melanogaster</italic> and other insect species [<xref rid="elu013-B51" ref-type="bibr">51&#x02013;53</xref>], <italic>Danio rerio</italic> [<xref rid="elu013-B34" ref-type="bibr">34</xref>, <xref rid="elu013-B54" ref-type="bibr">54</xref>], <italic>Caenorhabditis elegans</italic> [<xref rid="elu013-B55" ref-type="bibr">55</xref>], <italic>Xenopus laevis</italic> [<xref rid="elu013-B56" ref-type="bibr">56</xref>, <xref rid="elu013-B57" ref-type="bibr">57</xref>], mouse [<xref rid="elu013-B58" ref-type="bibr">58</xref>, <xref rid="elu013-B59" ref-type="bibr">59</xref>], rat [<xref rid="elu013-B60" ref-type="bibr">60</xref>] and livestock, including pig and cow [<xref rid="elu013-B61" ref-type="bibr">61</xref>]. Plants are also accessible for TALEN-mediated gene editing, including not only model organisms such as <italic>Arabidopsis</italic> [<xref rid="elu013-B62" ref-type="bibr">62</xref>, <xref rid="elu013-B63" ref-type="bibr">63</xref>] but also crop plants such as rice [<xref rid="elu013-B64" ref-type="bibr">64</xref>] and tobacco [<xref rid="elu013-B65" ref-type="bibr">65</xref>]. Current efficiency varies usually from 10 to &#x0003e;50% with an average around 22% cells mutated [<xref rid="elu013-B66" ref-type="bibr">66</xref>, <xref rid="elu013-B67" ref-type="bibr">67</xref>]. We achieved TALEN cleavage efficiency of 18% when inducing a &#x0223c;0.7 kb deletion with two TALEN pairs in the mouse genome [<xref rid="elu013-B47" ref-type="bibr">47</xref>] (<xref ref-type="fig" rid="elu013-F4">Figure 4</xref>).
<fig id="elu013-F4" position="float"><label>Figure 4:</label><caption><p>An example of genomic deletion achieved with two TALEN pairs [<xref rid="elu013-B47" ref-type="bibr">47</xref>]. Shown are relative positions of DSBs introduced by TALENs. Individual TALEN recognition sites are shown in bold black letters. Nine founder mice carrying 10 deletion alleles were found among 51 animals originating from TALEN-injected zygotes. Deletion positions are listed in the extreme right column.</p></caption><graphic xlink:href="elu013f4p"/></fig></p><p>Early studies typically used NHEJ-mediated mutagenesis. DSB-driven HR with dsDNA donor templates was subsequently used as well, e.g. in human cells [<xref rid="elu013-B28" ref-type="bibr">28</xref>, <xref rid="elu013-B68" ref-type="bibr">68</xref>] and zebrafish zygotes [<xref rid="elu013-B69" ref-type="bibr">69</xref>]. Single strand oligonucleotides with &#x0223c;50 nt long arms of homology were used as a donor template for precise modifications in zebrafish and mouse models [<xref rid="elu013-B59" ref-type="bibr">59</xref>,<xref rid="elu013-B70" ref-type="bibr">70</xref>]. Furthermore, introduction of two DSBs simultaneously allows for additional genome alterations [<xref rid="elu013-B47" ref-type="bibr">47</xref>, <xref rid="elu013-B52" ref-type="bibr">52</xref>, <xref rid="elu013-B61" ref-type="bibr">61</xref>]. A widely applied and generally successful approach is microinjection of <italic>in vitro</italic> synthesized mRNAs encoding a custom TALEN pair into the zygote [<xref rid="elu013-B47" ref-type="bibr">47</xref>, <xref rid="elu013-B59" ref-type="bibr">59&#x02013;61</xref>, <xref rid="elu013-B69" ref-type="bibr">69</xref>, <xref rid="elu013-B70" ref-type="bibr">70</xref>]. This allows for fast and effective preparation of knock-out models [<xref rid="elu013-B71" ref-type="bibr">71</xref>]. Heterozygous mutant mice can be prepared within 18 weeks [<xref rid="elu013-B47" ref-type="bibr">47</xref>, <xref rid="elu013-B59" ref-type="bibr">59</xref>]. Biallelic mutations may also occur [<xref rid="elu013-B47" ref-type="bibr">47</xref>, <xref rid="elu013-B56" ref-type="bibr">56</xref>, <xref rid="elu013-B61" ref-type="bibr">61</xref>, <xref rid="elu013-B70" ref-type="bibr">70</xref>], which strongly reduce time necessary for preparation of homozygous animals. We have produced and analyzed a knock-out mouse model within a year with frequency of genomic deletion of &#x0223c;20%; 1/51 founder animals carried the desired deletion on both chromosomes [<xref rid="elu013-B47" ref-type="bibr">47</xref>].</p><p>TALENs are highly specific and can distinguish sites, which differ only in two mismatched bases [<xref rid="elu013-B13" ref-type="bibr">13</xref>, <xref rid="elu013-B54" ref-type="bibr">54</xref>]. Mussolino <italic>et al.</italic> [<xref rid="elu013-B13" ref-type="bibr">13</xref>] compared cytotoxicity and specificity of a CCR5-specific TALEN pair with a well-established ZFN pair. Off-target site in highly homologous CCR2 gene differed from CCR5 only in one base and 5&#x02032;-T<sup>0</sup>. The TALEN pair induced only 1% mutation in the <italic>CCR2</italic> off-target, whereas the ZFN pair induced 11%. Moreover, 2-fold higher cell survival was reported for the TALEN pair. Numerous other results suggest that TALENs are more mutagenic and less cytotoxic than ZFN [<xref rid="elu013-B34" ref-type="bibr">34</xref>, <xref rid="elu013-B39" ref-type="bibr">39</xref>, <xref rid="elu013-B66" ref-type="bibr">66</xref>, <xref rid="elu013-B72" ref-type="bibr">72</xref>, <xref rid="elu013-B73" ref-type="bibr">73</xref>].</p><p>Enhanced TALEN-mediated gene disruption in rat zygotes was achieved by co-injection of engineered TALENs with Exonuclease 1 [<xref rid="elu013-B74" ref-type="bibr">74</xref>] or Trex exonuclease [<xref rid="elu013-B75" ref-type="bibr">75</xref>], which degrade one DNA strand in DSB site and therefore promote alternative mutagenic correction pathway [<xref rid="elu013-B74" ref-type="bibr">74</xref>]. Mutagenicity can be further improved by adoption of the more effective FokI nuclease such as <italic>Sharkey</italic> [<xref rid="elu013-B76" ref-type="bibr">76</xref>] or by transient hypothermia [<xref rid="elu013-B28" ref-type="bibr">28</xref>].</p><p>Superior TALEN specificity can be achieved by adopting a heterodimeric FokI architecture, by mutating cationic residues in TALE C-terminal domain [<xref rid="elu013-B31" ref-type="bibr">31</xref>], or via fusion with other cleavage domains with intrinsic sequence specificity such as meganucleases (MegaTALs) or TevI nuclease. Recently reported MegaTALs are compact, active and hyper-specific endonucleases valuable for future widespread, safe and reliable therapeutic use [<xref rid="elu013-B75" ref-type="bibr">75</xref>, <xref rid="elu013-B77" ref-type="bibr">77</xref>]. TevI may work either as a monomeric nuclease (fused to N-terminus of TALE array over a TevI native linker) or as a nicking enzyme (fused to C-terminus of TALE array over shorter artificial linker), cleaving only one DNA strand [<xref rid="elu013-B78" ref-type="bibr">78</xref>]. The TevI cleavage domain (only &#x0223c;200 aa) has degenerated site specificity (CN&#x02191;NN&#x02193;GN), which limits possible target site selection, but substantially reduces the TALEN size [<xref rid="elu013-B78" ref-type="bibr">78</xref>]. Targeted nickases could be used to promote gene correction via HR in selected loci, with reduced cytotoxicity, because no DSBs are created [<xref rid="elu013-B79" ref-type="bibr">79</xref>, <xref rid="elu013-B80" ref-type="bibr">80</xref>].</p></sec><sec><title>Gene regulation with TALEs-DBDs</title><p>TALE DBDs were used not only for gene editing but also for targeted endogenous gene regulation in a form of artificial TALE transcription factors (<xref ref-type="fig" rid="elu013-F3">Figure 3</xref>). The first study demonstrated activation of plant genes in <italic>Arabidopsis</italic> using a native AvrBs3 scaffold with designed CRD matching their promoters [<xref rid="elu013-B33" ref-type="bibr">33</xref>]. Zhang <italic>et al.</italic> [<xref rid="elu013-B14" ref-type="bibr">14</xref>] developed an artificial TALE activator (<xref ref-type="fig" rid="elu013-F3">Figure 3</xref>B) using a truncated scaffold fused to the VP64 activation domain (tetrameric version of VP16 activation domain from <italic>Herpes simplex</italic> virus) and successfully induced expression of <italic>SOX2</italic> and <italic>KLF4</italic> in human cells but failed to activate <italic>OCT4</italic> and <italic>c-MYC</italic> genes [<xref rid="elu013-B14" ref-type="bibr">14</xref>]. Similarly, two other groups used different TALE architectures for activation of human genes with the VP16 domain [<xref rid="elu013-B28" ref-type="bibr">28</xref>, <xref rid="elu013-B81" ref-type="bibr">81</xref>].</p><p>Activation of <italic>Oct4</italic> gene was achieved with a TALE-VP16 activator in murine embryonic stem cells and derived neural stem cells [<xref rid="elu013-B82" ref-type="bibr">82</xref>]. TALE-mediated gene activation seemed to depend on the binding-site position in a target promoter and consequent interactions with basal transcription factors. Authors also demonstrated that methylation of target promoters impairs TALE activity and that specific activation of silenced genes is possible once cells are treated with low concentration of histone deacetylases and/or DNA methyltransferases inhibitors [<xref rid="elu013-B82" ref-type="bibr">82</xref>]. Negative effects of DNA methylation on TALE binding can be solved by using NG and N* RVDs, which allow for accommodating 5&#x02032;-methylcytosine [<xref rid="elu013-B26" ref-type="bibr">26</xref>, <xref rid="elu013-B83" ref-type="bibr">83</xref>]. A set of human genes including non-coding microRNA cluster miR-302/367 was activated in another study, which also showed that using multiple TAL Effector based transcriptiont factors (TALE-TFs) targeting a single gene has a synergistic effect on target expression [<xref rid="elu013-B84" ref-type="bibr">84</xref>].</p><p>TALE fusions with effector domains offer a broad range of applications, ranging from simple locus-specific transcriptional activation and repression [<xref rid="elu013-B82" ref-type="bibr">82</xref>, <xref rid="elu013-B85" ref-type="bibr">85</xref>], through direct induction of epigenetic changes on DNA [<xref rid="elu013-B86" ref-type="bibr">86</xref>] or on histones [<xref rid="elu013-B87" ref-type="bibr">87</xref>], to using them for visualization and pull-down of specific genomic loci [<xref rid="elu013-B88" ref-type="bibr">88&#x02013;91</xref>].</p></sec><sec><title>Design and assembly of TALE repeat domain</title><p>Several rules for rational design of TALE-CRD (and inherently for the selection of target site in DNA) could be inferred from known properties of particular repeat types and from the TALE-DNA-binding mode:
<list list-type="bullet"><list-item><p>Select target sites with 5&#x02032;-T<sup>0</sup> base preceding the CRD-specified sequence. If that is not possible, one can use reengineered scaffold with unrestricted specificity for 5&#x02032;-N<sup>0</sup> [<xref rid="elu013-B38" ref-type="bibr">38</xref>].</p></list-item><list-item><p>Confirm that your selected target site is truly unique (e.g. not representing a unique polymorphism within a highly repetitive element).</p></list-item><list-item><p>Although optimal repeat lengths likely vary for individual cognate sequences [<xref rid="elu013-B31" ref-type="bibr">31</xref>] as a rule of thumb [<xref rid="elu013-B9" ref-type="bibr">9</xref>, <xref rid="elu013-B48" ref-type="bibr">48</xref>, <xref rid="elu013-B59" ref-type="bibr">59</xref>], we recommend at least 14 repeats for each TALEN in a pair and 18&#x02013;20 repeats for TALE transcription factors.</p></list-item><list-item><p>Include at least four evenly positioned strong RVDs (e.g. HD &#x0003e; C, NG &#x0003e; T or NN &#x0003e; G/A), especially at termini of CRD to stabilize TALE-DNA interaction [<xref rid="elu013-B27" ref-type="bibr">27</xref>, <xref rid="elu013-B32" ref-type="bibr">32</xref>]</p></list-item><list-item><p>Avoid stretches of more than three identical RVDs, especially of NG, which was shown to adopt a deformed fold even with three repeats in a row [<xref rid="elu013-B29" ref-type="bibr">29</xref>].</p></list-item><list-item><p>Use NH for targeting G instead of NN, if discrimination between A and G is necessary [<xref rid="elu013-B29" ref-type="bibr">29</xref>].</p></list-item><list-item><p>Use NI for specific recognition of A along with sufficiently strong RVDs [<xref rid="elu013-B29" ref-type="bibr">29</xref>].</p></list-item><list-item><p>Use validated TALE scaffold, which includes whole NTR (&#x0223c;150 aa) and suitable C-terminal linker to the effector domain. One of the most common scaffolds established in multiple organisms is Miller&#x02019;s [<xref rid="elu013-B28" ref-type="bibr">28</xref>]. Also Mussolino&#x02019;s [<xref rid="elu013-B13" ref-type="bibr">13</xref>] and Zhang&#x02019;s [<xref rid="elu013-B14" ref-type="bibr">14</xref>] architectures are reliable and were used repeatedly.</p></list-item><list-item><p>Finally, we highly recommend to search for online tools for TALEN design and off-targeting analysis, which become increasingly available. Several of them are listed in <xref ref-type="table" rid="elu013-T1">Table 1</xref>.</p></list-item></list>
<table-wrap id="elu013-T1" position="float"><label>Table 1:</label><caption><p>Selected TALEN design web tools</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Tool</th><th rowspan="1" colspan="1">URL</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">E-TALEN</td><td rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.e-talen.org/E-TALEN/">http://www.e-talen.org/E-TALEN/</ext-link></td><td rowspan="1" colspan="1">[<xref rid="elu013-B92" ref-type="bibr">92</xref>]</td></tr><tr><td rowspan="1" colspan="1">tDnA</td><td rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://baolab.bme.gatech.edu/Research/BioinformaticTools/assembleTALSequences.html">http://baolab.bme.gatech.edu/Research/BioinformaticTools/assembleTALSequences.html</ext-link></td><td rowspan="1" colspan="1">[<xref rid="elu013-B93" ref-type="bibr">93</xref>, <xref rid="elu013-B94" ref-type="bibr">94</xref>]</td></tr><tr><td rowspan="1" colspan="1">TALE-NT</td><td rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="https://tale-nt.cac.cornell.edu/node/add/talen">https://tale-nt.cac.cornell.edu/node/add/talen</ext-link></td><td rowspan="1" colspan="1">[<xref rid="elu013-B95" ref-type="bibr">95</xref>]</td></tr><tr><td rowspan="1" colspan="1">TALeffectors</td><td rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://taleffectors.genome-engineering.org/tools/">http://taleffectors.genome-engineering.org/tools/</ext-link></td><td rowspan="1" colspan="1">[<xref rid="elu013-B96" ref-type="bibr">96</xref>]</td></tr><tr><td rowspan="1" colspan="1">Mojo Hand</td><td rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.talendesign.org/">http://www.talendesign.org/</ext-link></td><td rowspan="1" colspan="1">[<xref rid="elu013-B97" ref-type="bibr">97</xref>]</td></tr></tbody></table></table-wrap></p><p>Because the assembly of designed TALE DBDs from nearly identical repeats was challenging for classical cloning techniques, several platforms have emerged for efficient and rapid (less than a week) construction of expression plasmids containing a TALE scaffold with a designed DBD (reviewed in [<xref rid="elu013-B48" ref-type="bibr">48</xref>]). A widely used platform is the &#x02018;Golden Gate Cloning&#x02019;, which allows for highly efficient assembly of designed TALEs in a single reaction [<xref rid="elu013-B14" ref-type="bibr">14</xref>, <xref rid="elu013-B62" ref-type="bibr">62</xref>, <xref rid="elu013-B81" ref-type="bibr">81</xref>, <xref rid="elu013-B98" ref-type="bibr">98&#x02013;100</xref>]. Recent advances in TALEN assembly methods include ligation-independent cloning [<xref rid="elu013-B101" ref-type="bibr">101</xref>] and solid-phase cloning such as Fast Ligation-based Automatable Solid-phase High-throughput platform for large scale assembly of TALENs (FLASH) [<xref rid="elu013-B67" ref-type="bibr">67</xref>] and Iterative Capped Assembly (ICA) [<xref rid="elu013-B102" ref-type="bibr">102</xref>], the latter allowing for a rapid automatized robotic assembly with a high-throughput capability. Needless to say, custom TALE nucleases are also available from numerous commercial sources.</p></sec></sec><sec><title>SUMMARY AND OUTLOOK</title><p>Simple design, fast and low-cost assembly, high specificity combined with low cytotoxicity and a practically unlimited target site selection make TALE DBDs an excellent choice for DNA targeting. The TALEN technology has superior mutagenic potential associated with lower cytotoxicity and higher target specificity compared with ZFNs. Simple design and publicly available assembly toolkits allow for adoption of this technology by laboratories worldwide. Modular nature of TALE-DNA recognition, no significant inter-repeat context effects in contrast to zinc fingers and a possibility to target practically any sequence in are other important features. Although TALENs currently face competition from recently developed RNA-guided clustered regularly interspaced short palindromic repeats (CRISPR) approach [<xref rid="elu013-B103" ref-type="bibr">103</xref>], their outstanding potential for research and therapy remains undisputed.</p><p><boxed-text id="elu013-BOX1" position="float"><caption><title>Key points</title></caption><p>
<list list-type="bullet"><list-item><p>TALEs interact with cognate sequences via tandem repeats, which bind individual nucleotides.</p></list-item><list-item><p>A selected locus can be targeted with a designed TALE fused with an effector domain</p></list-item><list-item><p>TALENs allow for genetic alterations in virtually any model system.</p></list-item></list>
</p></boxed-text></p></sec></body><back><ack><title>Acknowledgement</title><p>The authors thank Radek Malik for help with preparation of the manuscript.</p></ack><bio id="d35e36"><p><bold>Radek Jankele</bold> is an undergraduate student at the Charles University in Prague. He is currently pursuing his MSc degree in the laboratory of Petr Svoboda.</p></bio><bio id="d35e47"><p><bold>Petr Svoboda</bold> received his PhD degree at the University of Pennsylvania in 2002. After a postdoctoral stay at the Friedrich Miescher Institute (Basel, Switzerland), he established his own group at the Institute of Molecular Genetics of the Czech Academy of Sciences in Prague in 2007.</p></bio><sec><title>FUNDING</title><p>This research was funded by the Czech Science Foundation. <funding-source>The Czech Science Foundation</funding-source> grant <award-id>P305/12/G034</award-id> and the <funding-source>Czech Ministry of Education Youth and Sports</funding-source> grant <award-id>KONTAKT II (LH13084)</award-id> (to P.S.). Institutional support was provided by <award-id>RVO 68378050</award-id>.</p></sec><ref-list><title>References</title><ref id="elu013-B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>D</given-names></name></person-group><article-title>Genome engineering with zinc-finger nucleases</article-title><source>Genetics</source><year>2011</year><volume>188</volume><fpage>773</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">21828278</pub-id></element-citation></ref><ref id="elu013-B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitinaite</surname><given-names>J</given-names></name><name><surname>Wah</surname><given-names>DA</given-names></name><name><surname>Aggarwal</surname><given-names>AK</given-names></name><etal/></person-group><article-title>FokI dimerization is required for DNA cleavage</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>10570</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9724744</pub-id></element-citation></ref><ref id="elu013-B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YG</given-names></name><name><surname>Chandrasegaran</surname><given-names>S</given-names></name></person-group><article-title>Chimeric restriction endonuclease</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>883</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7905633</pub-id></element-citation></ref><ref id="elu013-B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>RP</given-names></name><name><surname>Vorh&#x000f6;lter</surname><given-names>F-J</given-names></name><name><surname>Potnis</surname><given-names>N</given-names></name><etal/></person-group><article-title>Pathogenomics of Xanthomonas: understanding bacterium-plant interactions</article-title><source>Nat Rev Microbiol</source><year>2011</year><volume>9</volume><fpage>344</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21478901</pub-id></element-citation></ref><ref id="elu013-B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossier</surname><given-names>O</given-names></name><name><surname>Wengelnik</surname><given-names>K</given-names></name><name><surname>Hahn</surname><given-names>K</given-names></name><etal/></person-group><article-title>The Xanthomonas Hrp type III system secretes proteins from plant and mammalian bacterial pathogens</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>9368</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">10430949</pub-id></element-citation></ref><ref id="elu013-B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szurek</surname><given-names>B</given-names></name><name><surname>Marois</surname><given-names>E</given-names></name><name><surname>Bonas</surname><given-names>U</given-names></name><etal/></person-group><article-title>Eukaryotic features of the Xanthomonas type III effector AvrBs3: protein domains involved in transcriptional activation and the interaction with nuclear import receptors from pepper</article-title><source>Plant J</source><year>2001</year><volume>26</volume><fpage>523</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11439138</pub-id></element-citation></ref><ref id="elu013-B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boch</surname><given-names>J</given-names></name><name><surname>Scholze</surname><given-names>H</given-names></name><name><surname>Schornack</surname><given-names>S</given-names></name><etal/></person-group><article-title>Breaking the code of DNA binding specificity of TAL-type III effectors</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1509</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">19933107</pub-id></element-citation></ref><ref id="elu013-B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscou</surname><given-names>MJ</given-names></name><name><surname>Bogdanove</surname><given-names>AJ</given-names></name></person-group><article-title>A simple cipher governs DNA recognition by TAL effectors</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1501</fpage><pub-id pub-id-type="pmid">19933106</pub-id></element-citation></ref><ref id="elu013-B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boch</surname><given-names>J</given-names></name><name><surname>Bonas</surname><given-names>U</given-names></name></person-group><article-title>Xanthomonas AvrBs3 family-type III effectors: discovery and function</article-title><source>Ann Rev Phytopathol</source><year>2010</year><volume>48</volume><fpage>419</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">19400638</pub-id></element-citation></ref><ref id="elu013-B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>AN-S</given-names></name><name><surname>Bradley</surname><given-names>P</given-names></name><name><surname>Bogdanove</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>TAL effectors: function, structure, engineering and applications</article-title><source>Curr Opin Struct Biol</source><year>2013</year><volume>23</volume><fpage>93</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23265998</pub-id></element-citation></ref><ref id="elu013-B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaj</surname><given-names>T</given-names></name><name><surname>Gersbach</surname><given-names>CA</given-names></name><name><surname>Barbas Iii</surname><given-names>CF</given-names></name></person-group><article-title>ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering</article-title><source>Trends Biotechnol</source><year>2013</year><volume>31</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">23664777</pub-id></element-citation></ref><ref id="elu013-B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Chai</surname><given-names>J</given-names></name><etal/></person-group><article-title>Crystal structure of a TALE protein reveals an extended N-terminal DNA binding region</article-title><source>Cell Res</source><year>2012</year><volume>22</volume><fpage>1716</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">23147789</pub-id></element-citation></ref><ref id="elu013-B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mussolino</surname><given-names>C</given-names></name><name><surname>Morbitzer</surname><given-names>R</given-names></name><name><surname>Lutge</surname><given-names>F</given-names></name><etal/></person-group><article-title>A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>9283</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">21813459</pub-id></element-citation></ref><ref id="elu013-B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Lodato</surname><given-names>S</given-names></name><etal/></person-group><article-title>Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>149</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">21248753</pub-id></element-citation></ref><ref id="elu013-B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>AN-S</given-names></name><name><surname>Bradley</surname><given-names>P</given-names></name><name><surname>Cernadas</surname><given-names>RA</given-names></name><etal/></person-group><article-title>The crystal structure of TAL effector PthXo1 bound to its DNA target</article-title><source>Science</source><year>2012</year><volume>335</volume><fpage>716</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22223736</pub-id></element-citation></ref><ref id="elu013-B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casper-Lindley</surname><given-names>C</given-names></name><name><surname>Dahlbeck</surname><given-names>D</given-names></name><name><surname>Clark</surname><given-names>ET</given-names></name><etal/></person-group><article-title>Direct biochemical evidence for type III secretion-dependent translocation of the AvrBs2 effector protein into plant cells</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>8336</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12060777</pub-id></element-citation></ref><ref id="elu013-B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Gabriel</surname><given-names>DW</given-names></name></person-group><article-title>Xanthomonas avirulence/pathogenicity gene family encodes functional plant nuclear targeting signals</article-title><source>Mol Plant Microbe Interact</source><year>1995</year><volume>8</volume><fpage>627</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8589417</pub-id></element-citation></ref><ref id="elu013-B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Chittoor</surname><given-names>JM</given-names></name><etal/></person-group><article-title>AvrXa10 contains an acidic transcriptional activation domain in the functionally conserved C terminus</article-title><source>Mol Plant Microbe Interact</source><year>1998</year><volume>11</volume><fpage>824</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9675896</pub-id></element-citation></ref><ref id="elu013-B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>WG</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wills</surname><given-names>N</given-names></name><etal/></person-group><article-title>The C terminus of AvrXa10 can be replaced by the transcriptional activation domain of VP16 from the herpes simplex virus</article-title><source>Plant Cell</source><year>1999</year><volume>11</volume><fpage>1665</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">10488234</pub-id></element-citation></ref><ref id="elu013-B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lange</surname><given-names>O</given-names></name><name><surname>Schreiber</surname><given-names>T</given-names></name><name><surname>Schandry</surname><given-names>N</given-names></name><etal/></person-group><article-title>Breaking the DNA-binding code of Ralstonia solanacearum TAL effectors provides new possibilities to generate plant resistance genes against bacterial wilt disease</article-title><source>New Phytol</source><year>2013</year><volume>199</volume><fpage>773</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">23692030</pub-id></element-citation></ref><ref id="elu013-B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Atef</surname><given-names>A</given-names></name><name><surname>Piatek</surname><given-names>A</given-names></name><etal/></person-group><article-title>Characterization and DNA-binding specificities of Ralstonia TAL-like effectors</article-title><source>Mol Plant</source><year>2013</year><volume>6</volume><fpage>1318</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">23300258</pub-id></element-citation></ref><ref id="elu013-B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peisach</surname><given-names>E</given-names></name><name><surname>Pabo</surname><given-names>CO</given-names></name></person-group><article-title>Constraints for zinc finger linker design as inferred from X-ray crystal structure of tandem Zif268-DNA complexes</article-title><source>J Mol Biol</source><year>2003</year><volume>330</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12818197</pub-id></element-citation></ref><ref id="elu013-B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Structural basis for sequence-specific recognition of DNA by TAL effectors</article-title><source>Science</source><year>2012</year><volume>335</volume><fpage>720</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">22223738</pub-id></element-citation></ref><ref id="elu013-B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Revisiting the TALE repeat</article-title><source>Protein Cell</source><year>2014</year><volume>5</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">24622844</pub-id></element-citation></ref><ref id="elu013-B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bochtler</surname><given-names>M</given-names></name></person-group><article-title>Structural basis of the TAL effector-DNA interaction</article-title><source>Biol. Chem</source><year>2012</year><volume>393</volume><fpage>1055</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">23089535</pub-id></element-citation></ref><ref id="elu013-B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valton</surname><given-names>J</given-names></name><name><surname>Dupuy</surname><given-names>A</given-names></name><name><surname>Daboussi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Overcoming Transcription Activator-like Effector (TALE) DNA binding domain sensitivity to cytosine methylation</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>38427</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">23019344</pub-id></element-citation></ref><ref id="elu013-B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meckler</surname><given-names>JF</given-names></name><name><surname>Bhakta</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>M-S</given-names></name><etal/></person-group><article-title>Quantitative analysis of TALE&#x02013;DNA interactions suggests polarity effects</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>4118</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">23408851</pub-id></element-citation></ref><ref id="elu013-B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JC</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Qiao</surname><given-names>G</given-names></name><etal/></person-group><article-title>A TALE nuclease architecture for efficient genome editing</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>143</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21179091</pub-id></element-citation></ref><ref id="elu013-B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streubel</surname><given-names>J</given-names></name><name><surname>Bl&#x000fc;cher</surname><given-names>C</given-names></name><name><surname>Landgraf</surname><given-names>A</given-names></name><etal/></person-group><article-title>TAL effector RVD specificities and efficiencies</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><fpage>593</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22781676</pub-id></element-citation></ref><ref id="elu013-B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>ML</given-names></name><name><surname>Demorest</surname><given-names>ZL</given-names></name><name><surname>Starker</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Targeting G with TAL Effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable DI-residues</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e45383</fpage><pub-id pub-id-type="pmid">23028976</pub-id></element-citation></ref><ref id="elu013-B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilinger</surname><given-names>JP</given-names></name><name><surname>Pattanayak</surname><given-names>V</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><etal/></person-group><article-title>Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><fpage>429</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">24531420</pub-id></element-citation></ref><ref id="elu013-B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Kuo</surname><given-names>Y-C</given-names></name><etal/></person-group><article-title>Comprehensive interrogation of natural TALE DNA binding modules and transcriptional repressor domains</article-title><source>Nat Commun</source><year>2012</year><volume>3</volume><fpage>968</fpage><pub-id pub-id-type="pmid">22828628</pub-id></element-citation></ref><ref id="elu013-B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morbitzer</surname><given-names>R</given-names></name><name><surname>Romer</surname><given-names>P</given-names></name><name><surname>Boch</surname><given-names>J</given-names></name><etal/></person-group><article-title>Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>21617</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">21106758</pub-id></element-citation></ref><ref id="elu013-B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Heritable gene targeting in zebrafish using customized TALENs</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>699</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">21822242</pub-id></element-citation></ref><ref id="elu013-B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Complete decoding of TAL effectors for DNA recognition</article-title><source>Cell Res</source><year>2014</year><volume>24</volume><fpage>628</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">24513857</pub-id></element-citation></ref><ref id="elu013-B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;mer</surname><given-names>P</given-names></name><name><surname>Recht</surname><given-names>S</given-names></name><name><surname>Strauss</surname><given-names>T</given-names></name><etal/></person-group><article-title>Promoter elements of rice susceptibility genes are bound and activated by specific TAL effectors from the bacterial blight pathogen, <italic>Xanthomonas oryzae</italic> pv. Oryzae</article-title><source>New Phytologist</source><year>2010</year><volume>187</volume><fpage>1048</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">20345643</pub-id></element-citation></ref><ref id="elu013-B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahfouz</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Shamimuzzaman</surname><given-names>M</given-names></name><etal/></person-group><article-title><italic>De novo</italic>-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>2623</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21262818</pub-id></element-citation></ref><ref id="elu013-B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>BM</given-names></name><name><surname>Mercer</surname><given-names>AC</given-names></name><name><surname>Barbas</surname><given-names>CF</given-names><suffix>III</suffix></name></person-group><article-title>Directed evolution of the TALE N-terminal domain for recognition of all 5&#x02032; bases</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>9779</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">23980031</pub-id></element-citation></ref><ref id="elu013-B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Abil</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease</article-title><source>Mol BioSyst</source><year>2012</year><volume>8</volume><fpage>1255</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22301904</pub-id></element-citation></ref><ref id="elu013-B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>M</given-names></name><name><surname>Cermak</surname><given-names>T</given-names></name><name><surname>Doyle</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Targeting DNA double-strand breaks with TAL effector nucleases</article-title><source>Genetics</source><year>2010</year><volume>186</volume><fpage>757</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20660643</pub-id></element-citation></ref><ref id="elu013-B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capecchi</surname><given-names>MR</given-names></name></person-group><article-title>Essay: gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><fpage>507</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">15931173</pub-id></element-citation></ref><ref id="elu013-B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>DA</given-names></name><name><surname>Smigocki</surname><given-names>AC</given-names></name><name><surname>Camerini-Otero</surname><given-names>RD</given-names></name></person-group><article-title>Effect of insertions, deletions, and double-strand breaks on homologous recombination in mouse L cells</article-title><source>Mol Cell Biol</source><year>1985</year><volume>5</volume><fpage>684</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">3990689</pub-id></element-citation></ref><ref id="elu013-B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>KY</given-names></name><name><surname>Chekuri</surname><given-names>L</given-names></name><name><surname>Rauth</surname><given-names>S</given-names></name><etal/></person-group><article-title>Effect of double-strand breaks on homologous recombination in mammalian cells and extracts</article-title><source>Mol Cell Biol</source><year>1985</year><volume>5</volume><fpage>3331</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3870133</pub-id></element-citation></ref><ref id="elu013-B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>LP</given-names></name><name><surname>Chandrasegaran</surname><given-names>S</given-names></name></person-group><article-title>Functional domains in Fok I restriction endonuclease</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>4275</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1584761</pub-id></element-citation></ref><ref id="elu013-B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyon</surname><given-names>Y</given-names></name><name><surname>Vo</surname><given-names>TD</given-names></name><name><surname>Mendel</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures</article-title><source>Nat Methods</source><year>2010</year><volume>8</volume><fpage>74</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21131970</pub-id></element-citation></ref><ref id="elu013-B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szczepek</surname><given-names>M</given-names></name><name><surname>Brondani</surname><given-names>V</given-names></name><name><surname>Buchel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases</article-title><source>Nat Biotechnol</source><year>2007</year><volume>25</volume><fpage>786</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17603476</pub-id></element-citation></ref><ref id="elu013-B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flemr</surname><given-names>M</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Franke</surname><given-names>V</given-names></name><etal/></person-group><article-title>A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes</article-title><source>Cell</source><year>2013</year><volume>155</volume><fpage>807</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">24209619</pub-id></element-citation></ref><ref id="elu013-B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joung</surname><given-names>JK</given-names></name><name><surname>Sander</surname><given-names>JD</given-names></name></person-group><article-title>TALENs: a widely applicable technology for targeted genome editing</article-title><source>Nat Rev Mol Cell Biol</source><year>2013</year><volume>14</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">23169466</pub-id></element-citation></ref><ref id="elu013-B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavletich</surname><given-names>NP</given-names></name><name><surname>Pabo</surname><given-names>CO</given-names></name></person-group><article-title>Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A</article-title><source>Science</source><year>1991</year><volume>252</volume><fpage>809</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">2028256</pub-id></element-citation></ref><ref id="elu013-B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>WZ</given-names></name><etal/></person-group><article-title>TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>359</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">20699274</pub-id></element-citation></ref><ref id="elu013-B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Efficient and specific modifications of the <italic>Drosophila</italic> genome by means of an easy talen strategy</article-title><source>J Genet Genomics</source><year>2012</year><volume>39</volume><issue>5</issue><fpage>209</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">22624882</pub-id></element-citation></ref><ref id="elu013-B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name></person-group><article-title>Highly efficient and specific genome editing in silkworm using custom TALENs</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><issue>9</issue><fpage>e45035</fpage><pub-id pub-id-type="pmid">23028749</pub-id></element-citation></ref><ref id="elu013-B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group><article-title>Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases</article-title><source>Nat Commun</source><year>2012</year><volume>3</volume><fpage>1017</fpage><pub-id pub-id-type="pmid">22910363</pub-id></element-citation></ref><ref id="elu013-B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cade</surname><given-names>L</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Hwang</surname><given-names>WY</given-names></name><etal/></person-group><article-title>Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>8001</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">22684503</pub-id></element-citation></ref><ref id="elu013-B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>AJ</given-names></name><name><surname>Lo</surname><given-names>T-W</given-names></name><name><surname>Zeitler</surname><given-names>B</given-names></name><etal/></person-group><article-title>Targeted genome editing across species using ZFNs and TALENs</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>307</fpage><pub-id pub-id-type="pmid">21700836</pub-id></element-citation></ref><ref id="elu013-B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishibashi</surname><given-names>S</given-names></name><name><surname>Cliffe</surname><given-names>R</given-names></name><name><surname>Amaya</surname><given-names>E</given-names></name></person-group><article-title>Highly efficient bi-allelic mutation rates using TALENs in <italic>Xenopus tropicalis</italic></article-title><source>Biol Open</source><year>2012</year><volume>1</volume><fpage>1273</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23408158</pub-id></element-citation></ref><ref id="elu013-B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs)</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>17484</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23045671</pub-id></element-citation></ref><ref id="elu013-B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>YH</given-names></name><name><surname>Baek</surname><given-names>I-J</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Knockout mice created by TALEN-mediated gene targeting</article-title><source>Nat Biotechnol</source><year>2013</year><volume>31</volume><fpage>23</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23302927</pub-id></element-citation></ref><ref id="elu013-B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wefers</surname><given-names>B</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Ortiz</surname><given-names>O</given-names></name><etal/></person-group><article-title>Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>3782</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23426636</pub-id></element-citation></ref><ref id="elu013-B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tesson</surname><given-names>L</given-names></name><name><surname>Usal</surname><given-names>C</given-names></name><name><surname>M&#x000e9;noret</surname><given-names>S</given-names></name><etal/></person-group><article-title>Knockout rats generated by embryo microinjection of TALENs</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>695</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">21822240</pub-id></element-citation></ref><ref id="elu013-B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>DF</given-names></name></person-group><article-title>Efficient TALEN-mediated gene knockout in livestock</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>17382</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23027955</pub-id></element-citation></ref><ref id="elu013-B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cermak</surname><given-names>T</given-names></name><name><surname>Doyle</surname><given-names>EL</given-names></name><name><surname>Christian</surname><given-names>M</given-names></name><etal/></person-group><article-title>Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>e82</fpage><pub-id pub-id-type="pmid">21493687</pub-id></element-citation></ref><ref id="elu013-B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christian</surname><given-names>M</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Targeted mutagenesis of <italic>Arabidopsis thaliana</italic> using engineered TAL effector nucleases</article-title><source>G3</source><year>2013</year><volume>3</volume><fpage>1697</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">23979944</pub-id></element-citation></ref><ref id="elu013-B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Spalding</surname><given-names>MH</given-names></name><etal/></person-group><article-title>High-efficiency TALEN-based gene editing produces disease-resistant rice</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><fpage>390</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">22565958</pub-id></element-citation></ref><ref id="elu013-B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Transcription activator-like effector nucleases enable efficient plant genome engineering</article-title><source>Plant Physiol</source><year>2013</year><volume>161</volume><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23124327</pub-id></element-citation></ref><ref id="elu013-B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Oikonomou</surname><given-names>G</given-names></name><name><surname>Chiu</surname><given-names>CN</given-names></name><etal/></person-group><article-title>A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>2769</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">23303782</pub-id></element-citation></ref><ref id="elu013-B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Khayter</surname><given-names>C</given-names></name><etal/></person-group><article-title>FLASH assembly of TALENs enables high-throughput genome editing</article-title><source>Nat Biotechnol</source><year>2012</year><volume>30</volume><fpage>460</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22484455</pub-id></element-citation></ref><ref id="elu013-B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hockemeyer</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Kiani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic engineering of human pluripotent cells using TALE nucleases</article-title><source>Nat Biotechnol</source><year>2011</year><volume>29</volume><fpage>731</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">21738127</pub-id></element-citation></ref><ref id="elu013-B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>Y</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>TALEN-mediated precise genome modification by homologous recombination in zebrafish</article-title><source>Nat Methods</source><year>2013</year><volume>10</volume><fpage>329</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">23435258</pub-id></element-citation></ref><ref id="elu013-B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedell</surname><given-names>VM</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Campbell</surname><given-names>JM</given-names></name><etal/></person-group><article-title><italic>In vivo</italic> genome editing using a high-efficiency TALEN system</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>114</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23000899</pub-id></element-citation></ref><ref id="elu013-B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wefers</surname><given-names>B</given-names></name><name><surname>Panda</surname><given-names>SK</given-names></name><name><surname>Ortiz</surname><given-names>O</given-names></name><etal/></person-group><article-title>Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA</article-title><source>Nat Protoc</source><year>2013</year><volume>8</volume><fpage>2355</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">24177293</pub-id></element-citation></ref><ref id="elu013-B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A</given-names></name><name><surname>Lohmueller</surname><given-names>JJ</given-names></name><name><surname>Silver</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Engineering synthetic TAL effectors with orthogonal target sites</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>7584</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">22581776</pub-id></element-citation></ref><ref id="elu013-B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>FE</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Sander</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs)</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e37877</fpage><pub-id pub-id-type="pmid">22655075</pub-id></element-citation></ref><ref id="elu013-B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashimo</surname><given-names>T</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Sakuma</surname><given-names>T</given-names></name><etal/></person-group><article-title>Efficient gene targeting by TAL effector nucleases coinjected with exonucleases in zygotes</article-title><source>Sci Rep</source><year>2013</year><volume>3</volume><fpage>1253</fpage><pub-id pub-id-type="pmid">23409244</pub-id></element-citation></ref><ref id="elu013-B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boissel</surname><given-names>S</given-names></name><name><surname>Jarjour</surname><given-names>J</given-names></name><name><surname>Astrakhan</surname><given-names>A</given-names></name><etal/></person-group><article-title>megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>2591</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">24285304</pub-id></element-citation></ref><ref id="elu013-B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Gaj</surname><given-names>T</given-names></name><name><surname>Barbas</surname><given-names>CF</given-names></name></person-group><article-title>Directed evolution of an enhanced and highly efficient FokI cleavage domain for Zinc Finger Nucleases</article-title><source>J Mol Biol</source><year>2010</year><volume>400</volume><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">20447404</pub-id></element-citation></ref><ref id="elu013-B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>R</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Stoddard</surname><given-names>BL</given-names></name></person-group><article-title>Redesign of extensive protein-DNA interfaces of meganucleases using iterative cycles of <italic>in vitro</italic> compartmentalization</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>4061</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24591643</pub-id></element-citation></ref><ref id="elu013-B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beurdeley</surname><given-names>M</given-names></name><name><surname>Bietz</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Compact designer TALENs for efficient genome engineering</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><fpage>1762</fpage><pub-id pub-id-type="pmid">23612303</pub-id></element-citation></ref><ref id="elu013-B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><etal/></person-group><article-title>Precision genome engineering with programmable DNA-nicking enzymes</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>1327</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">22522391</pub-id></element-citation></ref><ref id="elu013-B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>CL</given-names></name><name><surname>Certo</surname><given-names>MT</given-names></name><name><surname>Mussolino</surname><given-names>C</given-names></name><etal/></person-group><article-title>Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>5560</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">22373919</pub-id></element-citation></ref><ref id="elu013-B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissler</surname><given-names>R</given-names></name><name><surname>Scholze</surname><given-names>H</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transcriptional activators of human genes with programmable DNA-specificity</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e19509</fpage><pub-id pub-id-type="pmid">21625585</pub-id></element-citation></ref><ref id="elu013-B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bultmann</surname><given-names>S</given-names></name><name><surname>Morbitzer</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>5368</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">22387464</pub-id></element-citation></ref><ref id="elu013-B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>D</given-names></name><name><surname>Yin</surname><given-names>P</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><etal/></person-group><article-title>Recognition of methylated DNA by TAL effectors</article-title><source>Cell Res</source><year>2012</year><volume>22</volume><fpage>1502</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">22945353</pub-id></element-citation></ref><ref id="elu013-B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Linder</surname><given-names>SJ</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><etal/></person-group><article-title>Robust, synergistic regulation of human gene expression using TALE activators</article-title><source>Nat Methods</source><year>2013</year><volume>10</volume><fpage>243</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23396285</pub-id></element-citation></ref><ref id="elu013-B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konermann</surname><given-names>S</given-names></name><name><surname>Brigham</surname><given-names>MD</given-names></name><name><surname>Trevino</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Optical control of mammalian endogenous transcription and epigenetic states</article-title><source>Nature</source><year>2013</year><volume>500</volume><fpage>472</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23877069</pub-id></element-citation></ref><ref id="elu013-B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Angstman</surname><given-names>JF</given-names></name><name><surname>Richardson</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins</article-title><source>Nat Biotechnol</source><year>2013</year><volume>31</volume><fpage>1137</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">24108092</pub-id></element-citation></ref><ref id="elu013-B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendenhall</surname><given-names>EM</given-names></name><name><surname>Williamson</surname><given-names>KE</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><etal/></person-group><article-title>Locus-specific editing of histone modifications at endogenous enhancers</article-title><source>Nat Biotechnol</source><year>2013</year><volume>31</volume><fpage>1133</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24013198</pub-id></element-citation></ref><ref id="elu013-B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrum</surname><given-names>SD</given-names></name><name><surname>Taverna</surname><given-names>SD</given-names></name><name><surname>Tackett</surname><given-names>AJ</given-names></name></person-group><article-title>Purification of a specific native genomic locus for proteomic analysis</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>e195</fpage><pub-id pub-id-type="pmid">24030711</pub-id></element-citation></ref><ref id="elu013-B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanisch</surname><given-names>K</given-names></name><name><surname>Schneider</surname><given-names>K</given-names></name><name><surname>Morbitzer</surname><given-names>R</given-names></name><etal/></person-group><article-title>Targeting and tracing of specific DNA sequences with dTALEs in living cells</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>e38</fpage><pub-id pub-id-type="pmid">24371265</pub-id></element-citation></ref><ref id="elu013-B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Reyes-Gutierrez</surname><given-names>P</given-names></name><name><surname>Pederson</surname><given-names>T</given-names></name></person-group><article-title>Visualization of repetitive DNA sequences in human chromosomes with transcription activator-like effectors</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>21048</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">24324157</pub-id></element-citation></ref><ref id="elu013-B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyanari</surname><given-names>Y</given-names></name><name><surname>Ziegler-Birling</surname><given-names>C</given-names></name><name><surname>Torres-Padilla</surname><given-names>ME</given-names></name></person-group><article-title>Live visualization of chromatin dynamics with fluorescent TALEs</article-title><source>Nat Struct Mol Biol</source><year>2013</year><volume>20</volume><fpage>1321</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">24096363</pub-id></element-citation></ref><ref id="elu013-B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heigwer</surname><given-names>F</given-names></name><name><surname>Kerr</surname><given-names>G</given-names></name><name><surname>Walther</surname><given-names>N</given-names></name><etal/></person-group><article-title>E-TALEN: a web tool to design TALENs for genome engineering</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>e190</fpage><pub-id pub-id-type="pmid">24003033</pub-id></element-citation></ref><ref id="elu013-B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname><given-names>EJ</given-names></name><name><surname>Cradick</surname><given-names>TJ</given-names></name><name><surname>Zhao</surname><given-names>CL</given-names></name><etal/></person-group><article-title>An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>e42</fpage><pub-id pub-id-type="pmid">24381193</pub-id></element-citation></ref><ref id="elu013-B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Fine</surname><given-names>EJ</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>SAPTA: a new design tool for improving TALE nuclease activity</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>e47</fpage><pub-id pub-id-type="pmid">24442582</pub-id></element-citation></ref><ref id="elu013-B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D.oyle</surname><given-names>EL</given-names></name><name><surname>Booher</surname><given-names>NJ</given-names></name><name><surname>Standage</surname><given-names>DS</given-names></name><etal/></person-group><article-title>TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>W117</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">22693217</pub-id></element-citation></ref><ref id="elu013-B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjana</surname><given-names>NE</given-names></name><name><surname>Cong</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A transcription activator-like effector toolbox for genome engineering</article-title><source>Nat Protoc</source><year>2012</year><volume>7</volume><fpage>171</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">22222791</pub-id></element-citation></ref><ref id="elu013-B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neff</surname><given-names>KL</given-names></name><name><surname>Argue</surname><given-names>DP</given-names></name><name><surname>Ma</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Mojo Hand, a TALEN design tool for genome editing applications</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>1</fpage><pub-id pub-id-type="pmid">23323762</pub-id></element-citation></ref><ref id="elu013-B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><etal/></person-group><article-title>Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>6315</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">21459844</pub-id></element-citation></ref><ref id="elu013-B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morbitzer</surname><given-names>R</given-names></name><name><surname>Elsaesser</surname><given-names>J</given-names></name><name><surname>Hausner</surname><given-names>J</given-names></name><etal/></person-group><article-title>Assembly of custom TALE-type DNA binding domains by modular cloning</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>5790</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21421566</pub-id></element-citation></ref><ref id="elu013-B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>E</given-names></name><name><surname>Gruetzner</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><etal/></person-group><article-title>Assembly of designer TAL Effectors by golden gate cloning</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e19722</fpage><pub-id pub-id-type="pmid">21625552</pub-id></element-citation></ref><ref id="elu013-B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name><surname>Schmidt</surname><given-names>T</given-names></name><name><surname>Kaiser</surname><given-names>V</given-names></name><etal/></person-group><article-title>A ligation-independent cloning technique for high-throughput assembly of transcription activator&#x02013;like effector genes</article-title><source>Nat Biotechnol</source><year>2012</year><volume>31</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">23242165</pub-id></element-citation></ref><ref id="elu013-B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briggs</surname><given-names>AW</given-names></name><name><surname>Rios</surname><given-names>X</given-names></name><name><surname>Chari</surname><given-names>R</given-names></name><etal/></person-group><article-title>Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>e117</fpage><pub-id pub-id-type="pmid">22740649</pub-id></element-citation></ref><ref id="elu013-B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mali</surname><given-names>P</given-names></name><name><surname>Esvelt</surname><given-names>KM</given-names></name><name><surname>Church</surname><given-names>GM</given-names></name></person-group><article-title>Cas9 as a versatile tool for engineering biology</article-title><source>Nat Methods</source><year>2013</year><volume>10</volume><fpage>957</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">24076990</pub-id></element-citation></ref></ref-list></back></article>